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ScienceDirectProteins effect a number of biological functions, from cellular
signaling, organization, mobility, and transport to catalyzing
biochemical reactions and coordinating an immune response.
These varied functions are often dependent upon
macromolecular interactions, particularly with other proteins.
Small-scale studies in the scientific literature report protein–
protein interactions (PPIs), but slowly and with bias towards
well-studied proteins. In an era where genomic sequence is
readily available, deducing genotype–phenotype relationships
requires an understanding of protein connectivity at proteome-
scale. A proteome-scale map of the protein–protein interaction
network provides a global view of cellular organization and
function. Here, we discuss a summary of methods for building
proteome-scale interactome maps and the current status and
implications of mapping achievements. Not only do
interactome maps serve as a reference, detailing global cellular
function and organization patterns, but they can also reveal the
mechanisms altered by disease alleles, highlight the patterns of
interaction rewiring across evolution, and help pinpoint
biologically and therapeutically relevant proteins. Despite the
considerable strides made in proteome-wide mapping, several
technical challenges persist. Therefore, future considerations
that impact current mapping efforts are also discussed.
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As the most important biological building blocks, proteins
mainly carry out their functions by interacting with other
biological macromolecules, including DNA, RNA, pro-
teins and small molecules such as lipids and metabolites.
Protein–protein interactions, in particular, are incredibly
diverse, as they execute a myriad of biological functions.
Generating a protein–protein interaction network map at
proteome-scale reveals the macromolecular connections
that underlie the biology of the cell [1]. Indeed, in order to
explore the link between genotype and phenotype and
deduce how genetic changes result in disease, an under-
standing of the cellular network of physical and functional
interactions involving proteins is critical [1–4]. As we look
to generate the richest and most complete network map
possible, we rely on the integration of experimentally
derived and computationally predicted interactions.
Characterization and application of existing networks
has proven useful and highlights the need for expanded
network information [5].
Experimental methods for building a
proteome-scale map of the interactome
network
There are a number of methods for mapping protein–
protein interactions. However, only a few methods are
amenable for high-throughput mapping. Recently, prote-
ome-scale interactome maps for human and a number of
model organisms have been generated using one of three
main techniques. Binary interactome network maps have
been generated using yeast two-hybrid (Y2H), and report
direct physical interactions. In contrast, co-complex asso-
ciations can be either direct or indirect protein–protein
interactions, and are detected using affinity purification
followed by mass spectrometry (AP-MS) or co-fraction-
ation with mass spectrometry (CO-FRAC) (Figure 1).
While all of these experimental methods can be adapted
to systematically survey the entire proteome, each tech-
nique has inherent benefits and limitations.
Binary interaction mapping by yeast two-hybrid (Y2H)
Binary mapping by Y2H detects direct physical interac-
tions between two proteins by the reconstitution of a
transcription factor that activates reporter gene expres-
sion and promotes yeast cell survival on appropriate
selective media (Figure 1a) [6]. Binary interactions iden-
tified using Y2H as the primary screening method are
validated by a number of orthogonal assays, and data fromCurrent Opinion in Structural Biology 2017, 44:201–210
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Schematic of systematic experimental methods for high-throughput proteome-scale mapping of protein–protein interactions. For each method
(left), network representation (middle) and principle (right) are depicted. (a) Binary mapping using yeast two-hybrid identifies direct physical
interactions between two proteins. (b) Co-complex mapping using AP-MS or co-fractionation with mass spectrometry identifies protein
associations, which may be either direct or indirect.such assays indicate that pairs found by this method are of
comparable quality as gold standard literature datasets
[5,7]. A recent systematic binary mapping study assayed
pairs of proteins from a space of 13 000  13 000 human
open reading frames (ORFs) and identified
14 000 protein–protein interactions (PPIs) among
4300 proteins [8]. Systematically generated binary
maps uniformly identify PPIs in the whole gene space,
avoiding sociological bias that may occur in small-scale
experiments or literature-curated interactome maps that
focus on well-studied genes [8]. This screening method
has therefore proven to be a useful tool, enumerating
binary interactions not only for human, but for a number
of model organisms as well, including Saccharomyces cer-
evisiae [9–11], Schizosaccharomyces pombe [12], Escherichia
coli [13], Caenorhabditis elegans [14,15], and Arabidopsis
thaliana [16]. While this method is easily scaled and
relatively inexpensive, it may fail to capture interactions
between proteins which rely on intermediary or scaffold
proteins (such as those between protein complex sub-
units), those involving proteins from specific subcellularCurrent Opinion in Structural Biology 2017, 44:201–210 compartments (such as membrane proteins), or those
which require post-translational modifications [17]. More-
over, this assay requires proteins to be expressed at non-
endogenous levels in the yeast nucleus. Such technical
requirements may limit the detection of PPIs that require
specific protein expression levels (such as protein com-
plexes with strict stoichiometry or stability), or may
contribute to the detection of biophysical interactions
between proteins that are not endogenously co-expressed
or co-localized.
Affinity purification and mass spectrometry (AP-MS)
In interactome mapping by AP-MS, epitope tags are
fused to bait proteins, and proteins associated with the
bait proteins are purified and identified by mass spec-
trometry (Figure 1b, top). Two of the latest screening
efforts utilizing this method focused on expanding the
human interactome network map. The BioPlex dataset
reports 23 700 protein–protein associations (PPAs)
among 7600 proteins, using 2600 bait proteins over-
expressed in HEK293T cells [18]. An alternative study,www.sciencedirect.com
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rated into HeLa cell chromosomes and thus were
expressed at near-endogenous expression levels and pat-
terns to identify interactions. The QUBIC dataset
includes 28 500 PPAs among 5500 proteins, resulting
from the expression of 1100 bait proteins [19]. The
investigation of quantitative stoichiometry and protein
abundance in the QUBIC dataset suggested that stable
complexes are relatively rare, accounting for only 10% of
human interactome. Weak, substoichiometric interac-
tions were more critical for maintaining the connectivity
of the overall PPI network [19].
AP-MS is efficient in the identification of stably associ-
ated and relatively abundant proteins. In particular, PPAs
involved in large protein complexes are more likely to be
found by AP-MS, as cooperation among multiple proteins
may provide the needed structural stability for complexes
[11,20]. This method would thereby generate a dataset
that is complementary to those constructed using binary
PPI mapping methods. However, AP-MS is limited in its
ability to detect transient associations, low-abundance
complexes, and interactions occurring in particular cell
types [21]. In addition, PPAs identified by AP-MS indi-
cate only co-complex associations. For protein complexes
in which a mechanistic understanding of assembly is
critical, further testing must be done to determine which
of these are direct physical interactions.
Co-fractionation and mass spectrometry
In contrast to Y2H and AP-MS, interactome mapping by
co-fractionation does not require exogenously introduced
ORFs or protein tags (Figure 1b, bottom). Instead, chro-
matographic and other biochemical separation methods of
cell extracts are carried out to generate hundreds to
thousands of fractions that are analyzed by mass spec-
trometry. Protein associations are inferred by co-elution
profiles of proteins, as well as weighting from various
functional criteria such as co-expression, genetic interac-
tions, domain co-occurrence, and co-evolutionary rates.
Havugimana et al. were the first to use this method at
proteome-scale, and identified 14 000 associations
among 3000 human proteins for 600 protein com-
plexes [22]. An additional effort published in 2016 from
the same research group, increased the size of the net-
work map, now composed of 28 000 PPAs between
4500 proteins [23]. The human interactome network
map derived from co-fractionation showed little evidence
for tissue specificity, as few cell type-specific proteins
were detected. Moreover, fewer interactions for low
abundance proteins were identified [23], and rigorous
computational algorithms are required to reconstruct high
confidence co-complex associations. This inference of co-
complex association may not be free of sociological bias,
as it relies on the quality of previously generated large-
scale datasets to train the algorithm and infer the
interactions.www.sciencedirect.com Regardless of the mapping strategy employed, protein–
protein interactome maps have relatively poor overlap.
This is true even when comparing maps generated with
the same assay. However, this can be put in perspective
when considering the many different technical parame-
ters that influence the detection of PPIs. The genes
queried, the strains or cell types used, and the presence
and orientation of proteins tags are all examples of the
many variables that impact the detection of PPIs [7,17].
Ultimately, the combination of maps generated with
different methods provides a more complete view of
interactome networks, since each method highlights a
different subset of the interactome.
In silico prediction of protein–protein
interactions
To fill in the gap between the low coverage of experi-
mentally determined interactome network maps and the
urgent need for more complete and detailed interactome
information, in silico prediction methods of protein–pro-
tein interactions have been developed. These facilitate
the prioritization of experimental efforts and further our
understanding of current biological questions.
Many types of information, such as phylogenetic profil-
ing, gene fusion, co-expression, conservation of gene
neighborhood, and gene ontology, can be used individu-
ally or together to predict protein–protein interactions
[24–29]. Rhodes et al. used a naive Bayes model that
combines information for ortholog interaction, co-expres-
sion, shared gene ontology terms, and enriched domain–
domain interaction pairs to predict novel interactions in
human [30]. Zhang et al. showed that 3D structural
information for protein complexes and protein monomers
can be very helpful in the prediction of PPIs, when
combined with non-structural-based methods [31]. With
the use of only protein sequence evolutionary coupling
information derived from carefully generated multiple
sequence alignments, interactions can be predicted with
high accuracy and at the resolution of single residues
[32]. With the combination of 3D docking methods such
as HADCOCK, it is possible to acquire protein complex
models with even atomic resolution. Finally, new inter-
actions can also be predicted by an algorithm that is
purely based on the topology of current network itself,
without knowing any additional biological information
[33].
While all computational methods rely on different kinds
of experimental data, such as sequencing, structural, gene
expression, and PPI data, issues such as errors, biases,
incompleteness, and misinterpretation of experimental
data will influence computational prediction results. The
underlying assumptions of computational methods dic-
tate the power of prediction. For example, sequence or
structural similarities may not always reflect preservation
of biophysical interactions across species. Moreover,Current Opinion in Structural Biology 2017, 44:201–210
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ical interactions. General network patterns may not be
correct for PPI networks. Even if computational predic-
tions can enrich positive interactions many folds better
than random, they still suffer from a relatively high false
positive rate. The reliability of each method and its
predictions must ultimately be assessed by subsequent
validation experiments.
Both experimental and predicted PPIs are catalogued in a
number of databases and are available to the scientific
community. Some major repositories, and their character-
istics, are listed in Table 1. A more detailed description of
selectedrepositorieshasbeenprovidedby Zahiri etal. [28].
Modelling PPIs
Since the functions of proteins rely on their unique and
dynamic three-dimensional structures in a physiological
environment, finer mapping of protein–protein interac-
tions is critical; incorporating structural information to
flesh out the molecular details of PPIs will allow us to
better understand fundamental cellular processes.
Experimentally derived structures of interacting proteins
provide the most detailed description of how PPIs are
formed, at times with atomic resolution. For example,
they can reveal detailed binding interface residue infor-
mation or can be used to calculate the affinity of the
interaction [34–37]. Such data can also further our under-
standing of how changes in a protein (e.g., mutations and
post-translational modifications) affect interaction or pro-
tein stability [38,39,40]. Notably, detailed structures are
critical for drug design and virtual screening of small
molecule inhibitors, and serve as a basis for studying
the dynamic features of protein complexes, such as con-
formational changes and allosteric effects [41].Table 1
Most widely used protein–protein interaction databases. The major 
provided
Name Characteristics 
BioGrid Curated protein and genetic interactions,
associations, and post-translational modi
major model organisms
IntAct PPIs derived from literature curation and 
individual user submissions
Interactome3D Structural annotation of PPIs for eighteen
STRING Known and predicted PPIs. Direct and in
associations with three-dimensional struc
Pathway commons Provides both pathways and interactions 
Mentha Aggregated data from PPI databases with
score that takes supporting evidences int
Current Opinion in Structural Biology 2017, 44:201–210 The structures of interacting proteins can be deduced by
experimental techniques such as X-ray crystallography,
NMR spectroscopy, and cryo-electron microscopy. How-
ever, obtaining a high quality complex structure is still
very time consuming and labor intensive, and it is rarely
used in early stage PPI studies as a result. Considering the
size of even small interactomes (e.g., 18 000 predicted
total interactions in S. cerevisiae [11]), it would be nearly
impossible to experimentally solve all structures. Alter-
natively, PPI structures can be predicted by methods that
incorporate data such as existing PPIs, structure tem-
plates, and single protein structures [42,43–45]. The
curation and integration of such data provides a vital
resource; an example of such an integral database is
Interactome3D, which provides detailed structural infor-
mation for 23 500 PPIs in eighteen organisms [42].
Uses and implications of proteome-scale
interactome maps
Once constructed, macromolecular interaction network
maps are characterized to determine how reported inter-
actions affect the organization, dynamics, and functions of
a given biological system.
Exploration of disease mechanisms
In the era of genomic sequencing, more genetic muta-
tions have been identified than have been functionally
characterized. Although over 100 000 mutant alleles asso-
ciated with Mendelian disorders, complex diseases, and
cancer have been catalogued, causal relationships have
yet to be determined in many cases [2,46,47]. It is
critical then to discriminate between disease-causing
and natural genomic variants, and to determine their
respective PPI patterns [2,8].
A proteome-scale map serves as a reference, allowing for
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Examples of applications of proteome-scale interactome network maps. A schematic of a network shows proteins (or nodes, indicated as circles)
and biophysical interactions (or edges, shown as solid lines). (a) Study of disease mechanisms. Top panel: analyses of network perturbations.
Mutations can lead to complete loss of the gene product (node removal, illustrated in red) or loss of specific interactions (edge removal, indicated
with a dashed orange line). Middle panel: disease-associated genes tend to form clusters, or disease gene modules. Bottom panel: an
interspecies interactome network map indicates the interactions between proteins of a host and pathogen. (b) Investigation of mechanisms of
evolution. Top panel: networks are rewired over evolutionary periods of time. New genes may arise either by the traditional method of gene
duplication and diversification (pink) or de novo (purple), generating new edges in the PPI network. Bottom panel: possible conservation of
protein–protein interactions (represented by the dashed lines) between orthologs of different species.Determining the loss or gain of key interactions (or edges)
of a particular mutant protein, relative to the unperturbed
protein, identifies the ‘edgotype.’ These changes in the
interaction profile of the mutant might contribute to a
resulting disease state, ultimately allowing for a link
between genotype and phenotype [3,4] (Figure 2a, top
panel). Analysis of binary interactions from the most
recent proteome-scale map of the human interactome
network highlights several examples of ‘edgetic’ alleles
(i.e., those which lose some, but not all, edges). For
example, Rolland et al. determined that R24H and
R24C mutations in CDK4, linked to melanoma, disrupt
binding to CDKN2C, while the common variants N41S
and S52N do not [8]. Interactions corresponding to
functional relationships are more likely to be disrupted
by disease-associated mutations than by common var-
iants. An unbiased approach to interactome mappingwww.sciencedirect.com has the potential to link uncharacterized genetic muta-
tions to disease phenotypes through altered physical
interactions [2].
A better understanding of disease mechanisms can also be
reached through the study of network topology, which
allows the identification of patterns in interactome net-
works. One approach, known as the disease module
hypothesis, is based on the observation that disease
proteins are not scattered randomly in the interactome,
but form topological modules where they tend to interact
more with each other than with proteins outside of this
neighborhood. These particularly well-connected sub-
graphs of proteins are called disease modules
(Figure 2a, middle panel) [1,48,49]. Based on this hypoth-
esis, Rolland et al. expanded the view of the functional
cancer landscape by demonstrating that known andCurrent Opinion in Structural Biology 2017, 44:201–210
206 Sequences and topologycandidate cancer gene products tend to be highly con-
nected in the interactome network [8]. There is growing
interest for the disease module hypothesis, as it implies
that we can generate lists of genes that are potentially
enriched for new candidate disease genes. Those candi-
dates are prioritized based on the fact that the number of
edges separating the gene products within modules is on
average lower than for random sets of gene products
[1,50]. Moreover, Kitsak et al. recently showed that the
tissue specificity of many diseases can be explained by
the integrity of expression of the disease module, rather
than by the expression of genes carrying the disease-
associated mutation alone [51].
Complementary to intraspecies resource maps, interspe-
cies maps of pathogen-host interactomes have been built
to study the global landscape of host perturbations by
pathogens (Figure 2a, bottom panel). One interactome
map published in 2012 illustrated the rewiring of the host
cell (Homo sapiens) network under viral perturbations
from four families of DNA tumor virus proteins [52].
Systematic analysis of host targets of viral proteins can
identify cancer genes with a success rate on par with
functional genomics and large-scale cataloguing of tumor
mutations [52].
Study of protein–protein interaction rewiring in evolution
To date, protein–protein interaction maps have been
completed for various model organisms, including S.
cerevisiae [9–11,53–55], S. pombe [12], A. thaliana [16],
Drosophila melanogaster [56] and C. elegans [14,15], among
others. Comparisons between these interactomes, with a
particular focus on orthologous proteins, allows for the
study of network evolution (Figure 2b, bottom panel),
and allows us to see changes beyond those in the genome.
Many studies have examined network evolution at vari-
ous scales, in both distantly and closely related species.
To study the conservation of PPI networks, Wan et al.
generated protein complex maps with a standardized
approach for nine species spanning a billion years of
evolutionary divergence [23]. Most of the interacting
proteins were conserved across those species, and thus
over one million high-confidence co-complex associations
for 120 eukaryotes with sequenced genomes were pre-
dicted. Metazoan complexes, or ‘new’ complexes, tend to
be enriched for roles related to multicellularity, whereas
‘old’ complexes are involved in core biological processes.
Moreover, larger complexes have been shown to be more
evolutionarily conserved, while small complexes are more
functionally unannotated and recently emerged in verte-
brate evolution [22,23].
To determine whether proteins retain the ability to
interact over evolutionary distances, an interspecies inter-
actome map was constructed [57]. Biophysical interac-
tions between human and budding yeast proteins wereCurrent Opinion in Structural Biology 2017, 44:201–210 identified and then functionally characterized. This
yeast–human inter-interactome map reveals that co-func-
tionality and binding ability are preserved. For example,
DNA repair proteins, human MLH1 and yeast Mlh1, are
both able to bind yeast Ntg2, suggesting that this ances-
tral interaction has been preserved despite differentiation
of the two species and their proteome. The construction
of inter-interactome network maps such as this permit the
examination of the relationship between conservation at
the level of sequence and three-dimensional structure
with functionality, and determine the effect of evolution
on biophysical and functional network coordination.
An interactome also evolves as it both gains and loses
interactions. A protein interactome map generated for A.
thaliana provides evidence of dynamic rewiring [16].
Paralogous pairs of proteins arising from gene duplication
events and sequence diversification (Figure 2b, top panel)
exhibited a range of interaction rewiring, measured as the
fraction of shared interactions, and therefore a range of
functional divergence. A recent study on a subset of
paralogous pairs in budding yeast showed surprising
results; instead of only providing robustness, gene dupli-
cation may increase mutational fragility in some cases.
Half of the paralogous pairs tested required each other’s
presence to maintain their interaction profile [58].
The birth of new interactions is of particular interest, and
a more recent question (Figure 2b, top panel). How do
new protein–protein interactions arise? Which mecha-
nisms might be used to introduce these new associations
in the normal cellular repertoire? It has been proposed
that non-functional interactions may represent one reser-
voir from which functional interactions may arise [57].
Additionally, the duplication and diversification of exist-
ing genes may result in the integration of new interactions
(Figure 2b, top panel). Alternatively, new interactions
may result from the de novo birth of genes. Open reading
frames, residing in non-genic regions of the genome and
showing evidence of transcription and translation, encode
short novel peptides. These so-called proto-genes, which
display intermediate features between non-genic
sequences and bona fide genes, offer adaptive potential
if their expression and interactions confer a fitness advan-
tage under adverse conditions [59]. While proto-genes
have been identified in a number of organisms, how they
participate in and re-shape the cell’s protein–protein
interactions has yet to be determined at proteome-scale
[60,61,62,63].
Considerations for future interactome
mapping efforts
Protein complexity
Protein interactome maps fail to consider the full com-
plexity of the human proteome, as generated by alterna-
tive splicing, post-translational modifications, somatic
hypermutation, and other such mechanismswww.sciencedirect.com
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Considerations for future interactome network mapping efforts. (a) Tissue-specific interactome network maps. Spatial, quantitative, and temporal
information will be integrated. (b) Interactome network maps including protein isoforms and post-translational modifications (PTMs). (c) Rewiring of
interactome networks during developmental stages. (d) Interactome network maps generated under specific conditions, such as induction of
stress.(Figure 3b). For example, due to technical challenges and
incomplete isoform annotation, human interactome maps
utilize the reference isoform; this corresponds to either
the longest or most abundantly expressed form of the
protein, though this definition varies by database [64].
Only small-scale screening efforts have begun to consider
the effects of alternative splicing on protein-binding
ability. For example, Corominas et al. generated an iso-
form interactome network map by screening alternatively
spliced variants of autism spectrum disorders (ASD)
expressed in the brain [65]. Interestingly, half of the
interactions in this network involved splicing variants,
thereby emphasizing the importance of protein isoforms
in interactome networks. An expanded study by Yang
et al. was the first to examine isoforms across large
numbers of genes (1500 human genes), including those
involved in Mendelian diseases [66]. Isoforms for these
genes were cloned from five different tissues and
screened by Y2H against 15 000 human ORF clones
to determine protein interaction profiles. While some
interactions were shared, others were found to bewww.sciencedirect.com isoform-specific. The degree to which interactions are
shared may be an approximate measure of shared func-
tion, and may allow for the elucidation of redundancy in
protein interaction networks [58]. Post-translational mod-
ifications (PTMs) also contribute to protein complexity
and mediate conditional interactions; recent efforts to
identify PPIs that create or rely on PTMs have been
reviewed by Woodsmith and Stelzl [67]. More effort will
be required to better understand the degree to which
protein complexity affects the interactome of various
organisms.
Tissue specificity
Current protein interactome network maps provide a vast
overview of the biophysical interactions between pro-
teins. However, they often fail to incorporate or fully
explore tissue specificity. Indeed, in any given tissue or
cell type, only a portion of all possible PPIs will be
relevant. Incorporation of gene expression data, such as
those collected by the Genotype-Tissue Expression
(GTEx) Project, will permit the construction of tissue-Current Opinion in Structural Biology 2017, 44:201–210
208 Sequences and topologyspecific subnetworks (Figure 3a). A study of tissue-spe-
cific exons by Ellis et al. determined that these regions
were likely to be flexible and form interaction surfaces
[68]. This systematic assessment of neural-regulated
exons provides evidence that alternatively spliced exons
rewire interactions to generate tissue-specific networks.
Interaction dynamics
Identification of PPIs by biophysical methods reveals
only qualitative information. For example, current inter-
actome maps generated by Y2H, AP-MS, or CO-FRAC
do not incorporate the dynamics of protein interaction
(Figure 3c,d). However, recent interest in quantitative
measures of PPI information has grown, spurring the
development of new experimental techniques, such as
several bimolecular complementation methods, proxim-
ity-ligation assays [69] and quantitative AP-MS [70].
Alternative methods such as LUMIER with BACON,
BRET, and FRET even allow for the determination of
interaction strength [69].
Closing remarks: growth and integration of
interactome data
The typical representation of the protein–protein inter-
actome map, that of ‘nodes’ and ‘edges’, is a simplified
network model. Sophisticated protein molecules become
non-differentiable nodes, and the details of protein inter-
action process degenerate into a simple line. Quantitative
and dynamic features, such as protein expression levels
and interaction strength, are not yet incorporated. How-
ever, even though the network model is simplified, it has
great value not only in integrating local PPI information
into a global picture, but also in providing an infrastruc-
ture where multi-layered information can be linked
together to unveil a more realistic description of the
protein interactome. Further efforts in interactome map-
ping, with integration of isoforms and protein variants, as
well as quantitative, spatial, and temporal information,
will permit a better understanding of a cell’s organization
and functioning, as well as disease mechanisms.
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